Exploring Oligonucleotide Therapeutics for CNS Repeat Expansion Disorders: Spotlight on Huntington’s Disease

Time: 9:30 am
day: Day Two


  • Key highlights from progress within our ASO approach against Huntington’s Disease
  • Lessons learned from our work to improve our drug development strategy moving forwards
  • Illustrating distribution across the brain in pre-clinical models